ghk-cu peptide patches Glow Up Patches, for glowing skin & hair growth Peptide GHK-CU Cream | Concierge

Frequency: Treatments can be performed every 14 days year-round

International status Healthcare provider considerations Healthcare providers who prescribe or recommend BPC-157 face potential: Disciplinary action from state medical boards Medical license implications (sanctions, restrictions, suspension) Malpractice liability (insurance often excludes experimental treatments) Federal regulatory enforcement Research and access Legitimate research pathways: Investigational New Drug (IND) application required for human research Institutional Review Board (IRB) approval required GMP standards required for research-grade materials Current access: Research peptide suppliers (variable quality) Some compounding pharmacies (legal status varies) Clinical trials (limited availability) Why this regulatory status exists The evidentiary position that drove the 2023 prohibition has not changed, and FDA staff cited the same reasoning in recommending against listing in 2026: Thin controlled clinical data : one randomised placebo-controlled trial, Ruenzi 2005 in ulcerative colitis, published only as a meeting abstract and too small to read

gastrointestinal tolerability remains the dominant limiting factor across the entire GLP-1-based class, oral or injectable

Reconstitution & Handling Guidance

For serious healing, injectable peptides are necessary